Case File №
#VI-2026-0297
Huaian Hanyou Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A Great | 7 | 8.1 | 6.5 | 10.0 | 14 Nov 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 1 | 4.7 | 4.7 | 4.7 | 27 Feb 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X N/A | 1 | 9.6 | 9.6 | 9.6 | 13 Feb 2025 |
| Andarine S4 | X N/A | 1 | 8.7 | 8.7 | 8.7 | 3 Jul 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 8.6 | 8.6 | 8.6 | 25 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 6.9 | 6.9 | 6.9 | 2 Apr 2025 |
| Cardiogen | X N/A | 1 | 7.0 | 7.0 | 7.0 | 3 Jul 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 7 May 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 7.5 | 7.5 | 7.5 | 3 Jun 2025 |
| Dapoxetine | X N/A | 1 | 9.0 | 9.0 | 9.0 | 11 Jun 2025 |
| Dianabol | X N/A | 1 | 9.6 | 9.6 | 9.6 | 20 Jun 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 8.4 | 8.4 | 8.4 | 21 May 2025 |
| Estradiol Cypionate | X N/A | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 |
| Hyaluronic acid | X N/A | 1 | 8.4 | 8.4 | 8.4 | 2 Apr 2025 |
| IGF-1 LR3 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 3 Jun 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 |
| KPV | X N/A | 1 | 7.4 | 7.4 | 7.4 | 13 Jun 2025 |
| LGD-4033 (Ligandrol) Raw | X N/A | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| Lipo-C 120mg | X N/A | 1 | 7.9 | 7.9 | 7.9 | 2 Jul 2025 |
| Liraglutide | X N/A | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 |
| MT-1 | X N/A | 1 | 8.7 | 8.7 | 8.7 | 20 Jun 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 9.5 | 9.5 | 9.5 | 2 Apr 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 9.0 | 9.0 | 9.0 | 20 Jun 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 |
| SS-31 | X N/A | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 |
| Stanozolol (Winstrol) Raw | X N/A | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 |
| Super Shred | X N/A | 1 | 6.2 | 6.2 | 6.2 | 20 Jun 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 7.5 | 7.5 | 7.5 | 24 Apr 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 9.0 | 9.0 | 9.0 | 3 Jul 2025 |
| Teriparatide | X N/A | 1 | 9.2 | 9.2 | 9.2 | 3 Jun 2025 |
| Testagen | X N/A | 1 | 8.6 | 8.6 | 8.6 | 11 Jun 2025 |
| Tirzepatide Raw | X N/A | 1 | 6.8 | 6.8 | 6.8 | 11 Jun 2025 |
| Trenbolone Enanthate | X N/A | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 |
| Turinabol | X N/A | 1 | 9.7 | 9.7 | 9.7 | 27 Feb 2025 |
| Vesugen | X N/A | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 |
| YK-11 Raw | X N/A | 1 | 8.2 | 8.2 | 8.2 | 16 Mar 2025 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.5 A | 20mg | 22.3mg | +11.4% | 96.67% | f7xw4m | Lab A | Community |
| 24 May 2026 | LGD-4033 (Ligandrol) Raw | 7.4 A | 1g | 1.2g | +15.3% | 95.94% | mynxdi | Lab E | Community |
| 24 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 10.0 A | 100g | 100.7g | +0.7% | 95.58% | 5hijv0 | Lab F | Public |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 9.5 A | 15mg | 16.5mg | +10.2% | 97.31% | x56rlz | Lab G | Community |
| 24 May 2026 | Retatrutide | 9.2 A | 24mg | 22.4mg | -6.7% | 99.80% | low | No Label / Silver Crimp / Green Cap | Lab G |
| 24 May 2026 | Selank 10mg + Semax 10mg Blend | 9.1 A | 50mg | 50.7mg | +1.3% | 98.68% | vtq7xr | Lab D | Public |
| 24 May 2026 | SS-31 | 8.3 A | 5mg | 4.6mg | -7.6% | 95.52% | gi023w | Lab G | Public |
| 23 May 2026 | BPC157 10mg + TB500 10mg Blend | 8.9 A | 15mg | 13.1mg | -12.8% | 99.24% | acvq60 | Lab G | Public |
| 23 May 2026 | KPV | 8.0 A | 2mg | 1.9mg | -2.8% | 95.80% | 9f8kns | Lab A | Community |
| 23 May 2026 | Stanozolol (Winstrol) Raw | 10.0 A | 5g | 4.7g | -5.7% | 99.43% | hvp60j | Lab G | Public |
| 23 May 2026 | Vesugen | 9.2 A | 2mg | 2.3mg | +17.0% | 96.41% | 016q6k | Lab E | Public |
| 23 May 2026 | YK-11 Raw | 9.0 A | 10g | 8.6g | -13.5% | 95.60% | 6ivegw | Lab E | Public |
| 23 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.6 A | 15mg | 13.0mg | -13.0% | 99.67% | mgrcwf | Lab B | Community |
| 21 May 2026 | Ostarine (MK-2866) | 8.2 A | 25mg | 27.5mg | +10.1% | 97.36% | c8s8s4 | Lab A | Community |
| 21 May 2026 | Testagen | 10.0 A | 30mg | 28.2mg | -6.0% | 96.00% | 06hqj3 | Lab C | Public |
| 21 May 2026 | Estradiol Cypionate | 8.2 A | 300mg/ml | 367.8mg/ml | +22.6% | 96.67% | ftguyb | Lab D | Public |
| 20 May 2026 | Retatrutide | 10.0 A | 10mg | 10.3mg | +3.0% | 99.90% | n/a | No Label / Silver Crimp / Yellow Cap | Lab E |
| 17 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.1 A | 50mg | 51.2mg | +2.4% | 96.96% | d78z5b | Lab E | Public |
| 26 Jan 2026 | Cardiogen | 7.7 A | 2mg | 2.0mg | -0.2% | 96.32% | 24m6vu | Lab A | Public |
| 22 Jan 2026 | Retatrutide | 6.5 B | 10mg | 10.9mg | +9.0% | 99.80% | n/a | No Label / Silver Crimp / Yellow Cap | Lab G |
| 19 Jan 2026 | Equipoise (Boldenone Undecylenate) | 8.0 A | 300mg/ml | 372.8mg/ml | +24.3% | 99.18% | uvx34w | Lab F | Public |
| 19 Jan 2026 | Liraglutide | 5.3 B | 50mg | 45.1mg | -9.8% | 98.03% | jcy85j | Lab F | Community |
| 6 Jan 2026 | Dapoxetine | 8.6 A | 50mg | 60.9mg | +21.8% | 95.07% | vm1o65 | Lab B | Community |
| 6 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.7 A | 15mg | 13.2mg | -12.1% | 97.43% | hmoupu | Lab G | Public |
| 29 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.6 A | 5mg | 5.2mg | +4.8% | 99.11% | wrb2io | Lab D | Community |
| 29 Dec 2025 | Super Shred | 8.0 A | 300mg/ml | 275.5mg/ml | -8.2% | 99.91% | c4pomc | Lab C | Public |
| 29 Dec 2025 | T4 (Levothyroxine) | 6.8 A | 50mg | 43.6mg | -12.7% | 95.96% | bdx488 | Lab F | Public |
| 18 Dec 2025 | Retatrutide | 7.7 A | 36mg | 40.5mg | +12.5% | 99.80% | n/a | White Label / Silver Crimp / Blue Cap | Lab G |
| 13 Dec 2025 | Retatrutide | 7.8 A | 10mg | 9mg | -10.0% | 99.60% | n/a | No Label / Silver Crimp / Yellow Cap | Lab G |
| 5 Dec 2025 | Andarine S4 | 8.8 A | 100mg | 121.2mg | +21.2% | 96.89% | m2kso8 | Lab G | Public |
| 5 Dec 2025 | Trenbolone Enanthate | 6.3 A | 300mg/ml | 259.4mg/ml | -13.5% | 98.72% | nnff75 | Lab D | Public |
| 24 Nov 2025 | Retatrutide | 9.1 A | 20mg | 19.87mg | -0.7% | 99.53% | low | No Label / Gold Crimp / Clear Cap | Lab A |
| 23 Nov 2025 | Teriparatide | 8.3 A | 5mg | 5.7mg | +13.8% | 97.27% | rdaqyc | Lab B | Public |
| 17 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.8 A | 15mg | 14.7mg | -2.2% | 98.41% | mb8q05 | Lab A | Public |
| 17 Nov 2025 | Tirzepatide Raw | 6.6 A | 100g | 89.1g | -10.9% | 99.97% | 3kkv33 | Lab A | Public |
| 14 Nov 2025 | Retatrutide | 6.5 B | 5mg | 4.7mg | -6.0% | 99.40% | n/a | No Label / Silver Crimp / Blue Cap | Lab G |
| 14 Nov 2025 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 7.1 A | 10g | 11.5g | +14.5% | 95.01% | 99lxvh | Lab F | Public |
| 14 Nov 2025 | Hyaluronic acid | 7.3 A | 50mg | 57.7mg | +15.3% | 95.84% | ewlkl4 | Lab F | Community |
| 14 Nov 2025 | IGF-1 LR3 | 9.5 A | 10mg | 11.2mg | +11.9% | 96.30% | lj8r81 | Lab E | Community |
| 14 Nov 2025 | MT-1 | 8.6 A | 10mg | 12.3mg | +23.5% | 98.53% | yo08vi | Lab F | Community |
| 14 Nov 2025 | Turinabol | 10.0 A | 25mg | 25.1mg | +0.4% | 96.48% | nlihqv | Lab F | Public |
| 5 Nov 2025 | LGD-4033 (Ligandrol) | 6.9 A | 20mg | 23.5mg | +17.7% | 98.92% | 1qbe3q | Lab E | Public |
| 5 Nov 2025 | Lipo-C 120mg | 6.6 A | 100mg/ml | 85.5mg/ml | -14.5% | 95.40% | g48vkd | Lab G | Public |
| 4 Nov 2025 | Dianabol | 9.9 A | 100mg | 94.8mg | -5.2% | 97.86% | 4kbgpk | Lab G | Community |
| 17 Oct 2025 | Tamoxifen (Nolvadex) | 10.0 A | 10mg | 11.0mg | +9.8% | 97.26% | sidbcw | Lab D | Public |
— END OF EVIDENCE LOG —